ResMed Announces Participation in the RBCCM Global Healthcare Conference
May 07 2024 - 4:05PM
ResMed (NYSE: RMD, ASX: RMD) today announced Dr. Carlos Nunez,
Chief Medical Officer, and Amy Wakeham, Chief Investor Relations
Officer, will participate in a fireside chat at the 2024 RBCCM
Global Healthcare Conference on Tuesday, May 14, 2024, beginning at
approximately 4:05 p.m. (Eastern Daylight Time) at the
InterContinental New York Barclay, in New York, NY.
More information about this event, including access to the live,
audio-only webcast, may be accessed by visiting
https://investor.resmed.com. The audio-only webcast replay will be
available approximately 24 hours after the live webcast ends and
will be accessible for the following thirty (30) days.
About ResMedAt ResMed (NYSE: RMD, ASX: RMD) we
pioneer innovative solutions that treat and keep people out of the
hospital, empowering them to live healthier, higher-quality lives.
Our digital health technologies and cloud-connected medical devices
transform care for people with sleep apnea, COPD, and other chronic
diseases. Our comprehensive out-of-hospital software platforms
support the professionals and caregivers who help people stay
healthy in the home or care setting of their choice. By enabling
better care, we improve quality of life, reduce the impact of
chronic disease, and lower costs for consumers and healthcare
systems in more than 140 countries. To learn more, visit
ResMed.com and follow @ResMed.
For
investors |
For
media |
+1 858.836.5000 |
+1 619.510.1281 |
investorrelations@resmed.com |
news@resmed.com |
ResMed (NYSE:RMD)
Historical Stock Chart
From Apr 2024 to May 2024
ResMed (NYSE:RMD)
Historical Stock Chart
From May 2023 to May 2024